Results 151 to 160 of about 66,582 (323)

Suppression of hyperbilirubinemia in the rat neonate by chromium-protoporphyrin. Interactions of metalloporphyrins with microsomal heme oxygenase of human spleen. [PDF]

, 1982
George S. Drummond, A Kappas
openalex   +1 more source

Fluoroscopic guidance for bulla identification during ventral bulla osteotomy in eight French bulldogs

Veterinary Record Open, Volume 12, Issue 1, June 2025.
Abstract Objective To describe the technique and outcome of fluoroscopy to guide bulla identification in French bulldogs during ventral bulla osteotomy. Materials and methods Medical records of eight French bulldogs with otitis media that underwent a fluoroscopic‐guided ventral bulla osteotomy between January 2020 and June 2023 were reviewed ...
Hui Yu Lu, Jeffery J. Biskup, Lea R. Mehrkens, Debbie Reynolds   +3 more
wiley   +1 more source

1418 INCREASED INCIDENCE OF EARLY ONSET HYPERBILIRUBINEMIA IN BREAST FED VERSUS BOTTLE FED INFANTS [PDF]

, 1981
Kenneth L Saul, David Warburton, Alan B. Lewis   +2 more
openalex   +1 more source

Comparison of Open Albumin Dialysis (OPAL) With Prometheus Fractionated Plasma Separation and Adsorption (FPSA) and Standard Medical Treatment for Acute‐On‐Chronic Liver Failure

Artificial Organs, Volume 49, Issue 6, Page 997-1011, June 2025.
The retrospective cohort study is the first to compare OPAL with Prometheus and hemodialysis for adult ACLF patients. Both extracorporeal liver support systems were comparably effective with regard to the reduction of bilirubin and creatinine levels surpassing the effects seen in hemodialysis. We recognized improvements in clinical scoring, such as the
Justa Friebus‐Kardash, Amina Louzi, Andreas Kribben, Hartmut H. Schmidt, Michael Jahn, Bartosz Tyczynski, Jassin Rashidi‐Alavijeh, Andreas Schütte, Amos Zeller   +8 more
wiley   +1 more source

A narrative review of metformin in pregnancy: Navigating benefit and uncertainty

Diabetes, Obesity and Metabolism, Volume 27, Issue S3, Page 16-30, June 2025.
Abstract Metformin is well‐established as a treatment for type 2 diabetes in non‐pregnant individuals. The low cost, acceptability and broad tolerability of metformin have also made it an attractive option for research into the treatment of other conditions associated with insulin resistance.
Robert P. McEvoy, Christine Newman, Aoife M. Egan, Fidelma P. Dunne   +3 more
wiley   +1 more source

Neonatal hyperbilirubinemia [PDF]

, 2008
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of neonatal ...
Brandes, Lisa
core  

Community health worker-led household screening and management of neonatal hyperbilirubinemia in rural Bangladesh: a cluster randomized control trial protocol [version 2; peer review: 1 approved, 2 approved with reservations]

Gates Open Research
Background Extreme hyperbilirubinemia leading to neurologic disability and death is disproportionately higher in low- and middle-income countries (LMIC) such as Bangladesh, and is largely preventable through timely treatment.
Mohammod Shahidullah, Md. Mahbubul Hoque, Muhammad Shariful Islam, Vinod K Bhutani, Eric M. Foote, Gary L Darmstadt, Mahbubur Rahman, Farjana Jahan, Tasnim Ahmed, Sarker Masood Parvez, Farzana Yeasmin, Rezaul Hasan, Sk Masum Billah, Shams El Arifeen   +13 more
doaj  

Hyperbilirubinemia Does Not Interfere with Hemoglobin Saturation Measured by Pulse Oximetry [PDF]

, 1989
Francis Veyckemans, Phillppe Baele, Jessica Guillaume, E. Willems, Annie Robert, Thierry Clerbaux   +5 more
openalex   +1 more source

Exchange transfusion safety and outcomes in neonatal hyperbilirubinemia

Journal of Perinatology, 2020
Mattie F. Wolf, J. Childers, Keyaria D. Gray, Caroline Chivily, M. Glenn, L. Jones, Mini Kpa, Taylor McMannen, Isaias Reyes, K. Zimmerman, R. Clark, R. Greenberg   +11 more
semanticscholar   +1 more source

Natural History of Idiosyncratic Drug‐Induced Liver Injury and Prognostic Models

Liver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background and Aims: Drug‐induced liver injury (DILI) remains a leading cause of acute liver failure worldwide. Drugs such as isoniazid, alone or in combination with other anti‐tuberculosis drugs, as well as a growing number of herbal and complementary medicines, have been implicated in most cases of acute liver failure in registry studies ...
Harshad C. Devarbhavi, Raúl J. Andrade
wiley   +1 more source